Costs and efficacy ofolanzapine and risperidone in schizophrenia
Introduction: schizophrenia is a serious and long lasting psychiatric disease. The new “atypical” antipsychotic drugs, introduced in the 90s, have substantially improved the effectiveness of medical treatments, compared to previous neuroleptic drugs. Nowadays they tend to be used as first choice dru...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SEEd Medical Publishers
2007-06-01
|
| Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
| Subjects: | |
| Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/241 |